Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide
- PMID: 3026617
Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide
Abstract
Human small cell lung cancers (SCLC) produce and secrete the regulatory peptide bombesin (BN) or its mammalian counterpart gastrin-releasing peptide (GRP). In addition, several SCLC tumor lines have been shown to express high affinity receptors for BN/GRP. On the basis of these findings, we investigated the effect of exogenously added BN and GRP on the soft agarose colony growth of a panel of human cell lines. In serum-free defined medium, colony formation of 9 of 10 SCLC cell lines was stimulated up to 150-fold by BN or GRP, with peak colony stimulation observed at 50 nM BN. In contrast, no stimulatory effect of BN was observed on nine non-SCLC cell lines. Although no stimulation of colony growth by BN was seen in serum-supplemented medium, addition of BN to the serum-free medium increased cloning efficiency to that achieved by serum in most of the SCLC cell lines. GRP 1-27, the active mammalian analogue of Bn, stimulated colony growth of SCLC cells similar to the manner of BN, while the physiologically inactive BN analogue, des-Leu (13)-Met (14)-BN, had no effect on colony growth. No correlation was observed in SCLC cell lines between the response of these cells to exogenous BN and the amount of cellular BN/GRP produced or the presence of BN receptors. These data suggest that BN/GRP may in some instances function as an autocrine growth factor for SCLC and indicate new ways for modulating SCLC growth in patients with this tumor.
Similar articles
-
Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.Cancer Res. 1992 Sep 15;52(18):4872-7. Cancer Res. 1992. PMID: 1325285
-
[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.Cancer Res. 1991 Apr 1;51(7):1798-802. Cancer Res. 1991. PMID: 1848479
-
Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.Clin Cancer Res. 2003 Oct 15;9(13):4953-60. Clin Cancer Res. 2003. PMID: 14581370
-
[The role of gastrin releasing peptide as a lung growth factor].Rev Mal Respir. 1992;9(2):125-37. Rev Mal Respir. 1992. PMID: 1565825 Review. French.
-
Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.Princess Takamatsu Symp. 1986;17:109-22. Princess Takamatsu Symp. 1986. PMID: 3332004 Review.
Cited by
-
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.Proc Natl Acad Sci U S A. 1988 Mar;85(6):1859-63. doi: 10.1073/pnas.85.6.1859. Proc Natl Acad Sci U S A. 1988. PMID: 2450349 Free PMC article.
-
Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.J Mol Neurosci. 2006;28(3):231-8. doi: 10.1385/JMN:28:3:231. J Mol Neurosci. 2006. PMID: 16691010
-
Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.J Mol Neurosci. 1993 Spring;4(1):29-40. doi: 10.1007/BF02736688. J Mol Neurosci. 1993. PMID: 8391295
-
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.J Clin Invest. 1990 Jun;85(6):1740-5. doi: 10.1172/JCI114630. J Clin Invest. 1990. PMID: 2161428 Free PMC article.
-
Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells.Cancer Res. 1995 Nov 1;55(21):4886-91. Cancer Res. 1995. PMID: 7585525 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous